Clinical Trial Update: SERETIDE Plus Tiotropium Versus Individual Components [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SERETIDE plus tiotropium versus the individual components in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Seretide (fluticasone propionate/salmeterol)
• tiotropium (tiotropium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED